Come up with a name for your new list and we'll add to it:
Procyrion raised a round of funding on January 31, 2013. Investors include
Texas Emerging Technology Fund.
Procyrion is developing minimally invasive treatment for heart failure patients who are too sick for medication. The Procyrion device consists of a small, continuous flow pump mounted within a self-ex…